CClinicalTrials.gg
CompletedNCT01877330Updated Mar 19, 2020

Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block

An interventional study of Interscalene block for shoulder arthroscopy in Shoulder Arthroscopy and Ultrasound-guided Interscalene Nerve Block, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-19.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective randomized clinical trial to determine where is the optimal location for local anesthetic injection for ultrasound guided interscalene nerve blocks. The investigators are investigating if local anesthetic deposited between the nerve roots is more effective than local anesthetic deposited in the interscalene groove.

02

Conditions studied

  • Shoulder Arthroscopy
  • Ultrasound-guided Interscalene Nerve Block

Keywords

  • shoulder arthroscopy
  • ultrasound guided nerve block
  • interscalene nerve block
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

ASA I-II patients who are 18 years and older and who are scheduled for shoulder arthroscopy are eligible for enrollment provided they do not have any of the following exclusion criteria.

Exclusion criteria

Exclusion Criteria:

  • chronic pain
  • high preoperative opioid requirement
  • age \< 18 years old
  • non-English speaking
  • contraindication to regional anesthesia (allergy to local anesthetics, coagulopathy, severe thrombocytopenia, pre-existing neuropathy in operative limb, infection at puncture site)
  • need for postoperative nerve function monitoring
  • patient refusal
  • dementia
  • pulmonary disease or low baseline oxygen saturation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
208 participants (actual)

Study arms

  • Active comparator
    Injection in interscalene groove

    Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove anterior and posterior to the brachial plexus nerves.

    Procedure: Interscalene block for shoulder arthroscopy

  • Active comparator
    Injection between nerve roots

    Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove inbetween the C5 and C6 nerve roots.

    Procedure: Interscalene block for shoulder arthroscopy

Interventions

  • ProcedureInterscalene block for shoulder arthroscopy
06

What researchers measure

Primary outcomes

  1. Onset of motor blockade

    Time to loss of shoulder abduction.

    Time frame: 1 hour from time of injection

Secondary outcomes

  1. Patient Satisfaction Score

    Time frame: 24 hours

  2. Opioid consumption

    Opioid consumption - perioperative and post discharge

    Time frame: 24 hours

  3. Quality of Nerve block

    onset of sensory block

    Time frame: 24 hours

  4. Incidence of post-operative nausea/vomiting

    Time frame: 24 hours

  5. Duration of nerve block

    Duration of analgesia from nerve block

    Time frame: 24 hours

  6. Number of needle passes

    Time frame: 1 hour

  7. Number of paresthesias

    number of paresthesia experience during nerve block

    Time frame: 1 hour

  8. Residual paresthesia

    incidence of residual paresthesias

    Time frame: 24 hour

07

Study locations

1 site
  • UCSF Orthopedic Institute
    San Francisco, California 94158, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01877330
Lead sponsor
University of California, San Francisco
Responsible party
Sponsor
First posted
Jun 13, 2013
Start date
Jan 2013
Primary completion
Mar 2016
Completion
Apr 2016
Last update
Mar 19, 2020

Study contacts

Pedram Aleshi, MD
principal investigator · University of California, San Francisco
Monica W Harbell, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion